Victrex Plc

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: GB0009292243
GBP
6.70
0.15 (2.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Victrex Plc stock-summary
stock-summary
Victrex Plc
Chemicals & Petrochemicals
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company's operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. The Company offers polyetheretherketone (PEEK) and polyaryletherketone (PAEK)-based polymer solutions. The Company's geographical locations include the United Kingdom; Europe, Middle East and Africa (EMEA); Americas, and Asia-Pacific. Its solutions are used in a range of applications, such as braking systems in automotive market, seal rings in energy market, mobile devices in electronics market and implanted devices in medical market. Its subsidiaries include Victrex Manufacturing Limited and Invibio Limited.
Company Coordinates stock-summary
Company Details
Victrex Technology Centre Hillhouse International, THORNTON CLEVELEYS None : FY5 4QD
stock-summary
Tel: 44 1253 89770044 1 253898121
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.62%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. lawrence Pentz
Non-Executive Independent Chairman of the Board
Mr. Jakob Sigurdsson
Chief Executive Officer, Executive Director
Mr. Richard Armitage
Chief Financial Officer, Executive Director
Mr. Martin Court
Chief Commercial Officer, Executive Director
Ms. Janet Ashdown
Non-Executive Independent Director
Mr. Brendan Connolly
Non-Executive Independent Director
Dr. Rosalind Rivaz
Senior Non-Executive Independent Director
Mr. David Thomas
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

GBP 570 Million (Small Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

706.20%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

6.61%

stock-summary
Price to Book

1.32